Save

Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia

In: Haematologia
Authors:
George Vaiopoulos
Search for other papers by George Vaiopoulos in
Current site
Google Scholar
PubMed Close
,
Evangelos Terpos
Search for other papers by Evangelos Terpos in
Current site
Google Scholar
PubMed Close
,
Konstantinos Anargyrou
Search for other papers by Konstantinos Anargyrou in
Current site
Google Scholar
PubMed Close
,
Maria Tsironi
Search for other papers by Maria Tsironi in
Current site
Google Scholar
PubMed Close
,
Konstantinos Konstantopoulos
Search for other papers by Konstantinos Konstantopoulos in
Current site
Google Scholar
PubMed Close
,
John Meletis
Search for other papers by John Meletis in
Current site
Google Scholar
PubMed Close
, and
Michael Samarkos
Search for other papers by Michael Samarkos in
Current site
Google Scholar
PubMed Close
Online Publication Date:
01 Jan 2002
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

Other access options

Rent on DeepDyve
Redeem Access Token
Title:
Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia
Article Type:
Research Article
DOI:
https://doi.org/10.1163/156855902320388023
Language:
English
Pages:
169–173
Keywords:
RAEB-T; BLASTS; REFRACTORY ANEMIA; SECONDARY LEUKEMIA; MELPHALAN TREATMENT; MYELODYSPLASTIC SYNDROME; RAEB; MDS; AML-MDS
In:
Haematologia
In:
Volume 32: Issue 2
Publisher:
VSP
E-ISSN:
1568-5594
Print ISSN:
0017-6559
Subjects:
Medical Sciences, Biology

Content Metrics

All Time Past 365 days Past 30 Days
Abstract Views 182 27 4
Full Text Views 95 0 0
PDF Views & Downloads 16 1 0